Albuminuria and hypertension are independently associated with circulating antipericyte autoantibodies in type 2 diabetic patients

Metabolism: Clinical and Experimental

Volumn 54, Issue 2, 2005, Pages 188-193

  Nayak, Ramesh C ^a,b   Agardh, Elizabet ^c   Kwok, Michael G K ^a   Farthing Nayak, Pamela J ^a,b   Lynch, Kristian ^c   Agardh, Carl David ^c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AUTOANTIBODY; BIOLOGICAL MARKER; CREATININE; HYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; BLOOD LEVEL; CELL CULTURE; CELL PROLIFERATION; COW; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PERICYTE; PRIORITY JOURNAL; PROTEINURIA; RETINA CELL; SYSTOLIC BLOOD PRESSURE; TISSUE INJURY;

AGED; ALBUMINURIA; AUTOANTIBODIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERICYTES; PREDICTIVE VALUE OF TESTS;

EID: 12944325308     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.08.011     Document Type: Article

References (29)

1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N. Engl. J. Med. 329 1993 977 986
2. UK Prospective Diabetes Study (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
3. The Diabetes Control and Complications Trial Research Group The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial Diabetes 44 1995 968 983
4. UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 1999 703 713
5. A. Grenfell, and P.J. Watkins Clinical diabetic nephropathy: natural history and complications Clin. Endocrinol. Metab. 15 1986 783 805
6. A.S. Krolewski, J.H. Warram, L.I. Rand, A.R. Christlieb, E.J. Busick, and C.R. Kahn Risk of proliferative diabetic retinopathy in juvenile-onset type I diabetes: a 40-yr follow-up study Diabetes Care 9 1986 443 452
7. M.A. Attawia, and R.C. Nayak Circulating antipericyte autoantibodies in diabetic retinopathy Retina 19 1999 390 400
8. R.C. Nayak, C.-D. Agardh, M.G.K. Kwok, H. Sternquist, P. Farthing-Nayak, and E. Agardh Circulating anti-pericyte autoantibodies are present in type 2 diabetic patients and are associated with non-proliferative retinopathy Diabetologia 46 2003 511 513
9. Anonymous World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects JAMA 277 1997 925 926
10. D.M. Nathan, C. Rosenbaum, and V.D. Protasowicki Single-void urine samples can be used to estimate quantitative microalbuminuria Diabetes Care 10 1987 414 418
11. A.J. Bakker Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration Diabetes Care 22 1999 307 313
12. T. Claudi, and J.G. Cooper Comparison of urinary albumin excretion rate in overnight urine and albumin creatinine ratio in spot urine in diabetic patients in general practice Scand. J. Prim. Health Care 19 2001 247 248
13. Early Treatment Diabetic Retinopathy Study Research Group Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12 Ophthalmology 98 Suppl. 5 1991 823 833
14. R.C. Nayak, and I.M. Herman Bovine retinal microvascular pericytes: isolation, propagation and identification C. Murray Methods in molecular medicine: angiogenesis protocols 2001 Humana Press Inc. Totowa 247 263
15. H.H. Parving, M.A. Gall, P. Skott, H.E. Jorgensen, H. Lokkegaard, and F. Jorgensen Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients Kidney Int. 41 1992 758 762
16. R. Donnelly, J.M. Yeung, and G. Manning Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes J. Hypertens. 21 Suppl. 1 2003 S7 S12
17. I. Suzuma, Y. Hata, A. Clermont, F. Pokras, S.L. Rook, and K. Suzuma Cyclic stretch and hypertension induce retinal expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2: potential mechanisms for exacerbation of diabetic retinopathy by hypertension Diabetes 50 2001 444 454
18. E. Agardh, G. Tallroth, B. Bauer, U. Cavallin-Sjoberg, and C.D. Agardh Retinopathy and nephropathy in insulin-dependent diabetics: an inconsistent relationship? Diabet. Med. 4 1987 248 250
19. C.E. Lloyd, R. Klein, R.E. Maser, L.H. Kuller, D.J. Becker, and T.J. Orchard The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) study J. Diabetes Complications 9 1995 140 148
20. C.E. Lloyd, and T.J. Orchard Diabetes complications: the renal-retinal link. An epidemiological perspective Diabetes Care 18 1995 1034 1036
21. B.M. Chavers, S.M. Mauer, R.C. Ramsay, and M.W. Steffes Relationship between retinal and glomerular lesions in IDDM patients Diabetes 43 1994 441 446
22. H.P. Chase, S.K. Garg, W.E. Jackson, M.A. Thomas, S. Harris, and G. Marshall Blood pressure and retinopathy in type I diabetes Ophthalmology 97 1990 155 159
23. A.S. Krolewski, M. Canessa, J.H. Warram, L.M. Laffel, A.R. Christlieb, and W.C. Knowler Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus N. Engl. J. Med. 318 1988 140 145
24. K. Norgaard, B. Feldt-Rasmussen, and T. Deckert Is hypertension a major independent risk factor for retinopathy in type 1 diabetes? Diabet. Med. 8 1991 334 337
25. T.J. Orchard From diagnosis and classification to complications and therapy. DCCT. Part II: diabetes control and complications trial Diabetes Care 17 1994 326 338
26. A.L.P. Caforio, J.H. Goldman, M.K. Baig, A.J. Haven, W.J. Dalla Libera, and W.J. McKenna Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression Heart 77 1997 62 67
27. G.F. Bottazzo, B.M. Dean, A.N. Gorsuch, A.G. Cudworth, and D. Doniach Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage Lancet 1 1980 668 672
28. J. Komulainen, M. Knip, R. Lounamaa, P. Vahasalo, J. Karjalainen, and E. Sabbak Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland study group Diabet. Med. 14 1997 532 537
29. K. Buschard, M. Hoy, K. Bokvist, H.L. Olsen, S. Madsbad, and P. Fredman Sulfatide controls insulin secretion by modulation of ATP-sensitive K(+)-channel activity and Ca(2+)-dependent exocytosis in rat pancreatic beta-cells Diabetes 51 2002 2514 2521